Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.09
Delayed Data
As of Jun 30
 -0.14 / -1.70%
Today’s Change
5.21
Today|||52-Week Range
22.20
-19.58%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close8.23
Today’s open8.25
Day’s range8.00 - 8.37
Volume651,208
Average volume (3 months)889,565
Market cap$289.2M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)-73.20%
Earnings growth (this year)-28.42%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
PRTKParatek Pharmaceutic...+0.35+2.58%
COLLCollegium Pharmaceut...-0.17-1.41%
AKBAAkebia Therapeutics ...+0.06+0.81%
ARDXArdelyx Inc+0.28+3.31%
Data as of 06/30/2016

Financials

Next reporting dateSeptember 12, 2016
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$47.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, Director &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers

Search for Jobs